SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

APE fuels culture. Backed by the best club in the world and hundreds of thousands of holders worldwide, it’s the token for digital and IRL communities, builders, creators, collectors, gamers, and beyond.  APE is the native gas token of ApeChain and is available across multiple ecosystems including Ethereum, Arbitrum, Solana and HyperLiquid.z  ApeCoin's mission is is to supercharge its ecosystem by supporting high-quality builders &amp; reinforcing 3 core pillars: ApeChain, Bored Ape Yacht Club, and Otherside.

ApeCoin

ApeCoin is seeing increased social media activity and speculative interest as traders track its recent volatility and volume-driven price movements. Community members are actively debating the token's potential for a momentum-based squeeze while remaining divided between those accumulating for a rebound and those skeptical of its long-term viability.

Index Coop is a decentralized autonomous organization (DAO) that builds structured DeFi products and strategy tokens. Index Coop offers a suite of sector index products, leverage and inverse products, and yield-generating products. The product suite runs on Set Protocol, an audited, self-custodial DeFi tool that allows for the creation and management of Ethereum-based (or ERC-20) tokens. Changes to the DAO are voted on by the owners of a governance token called INDEX and then implemented by a team of developers. INDEX holders wield voting power on a 1:1 basis, meaning one token equals one vote.

Index Cooperative

Index Cooperative is generating community buzz driven by its low circulating supply and potential as a DeFi infrastructure play, with investors actively discussing speculative price targets. While some participants express frustration over low volume and delisting concerns on certain exchanges, others are framing it as a "sleeping giant" primed for a breakout during the next altcoin cycle.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is seeing massive volatility and volume following a significant earnings report that highlighted strong infrastructure revenue growth. Investors are actively debating the sustainability of this rally, with intense community discussion focused on whether the stock's recent momentum reflects a fundamental shift in demand or if it remains overextended and prone to a rapid reversal.

Chip

Chip is experiencing intense volatility and community debate following its simultaneous listing on major trading platforms like Robinhood and Coinbase, which has driven massive speculative volume. Investors are divided between those betting on its long-term potential as an AI infrastructure utility token and skeptics who are labeling the rapid price swings as a classic pump-and-dump scheme.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying on massive volume amid heavy speculation regarding a potential strategic partnership with Amazon and its role within the broader AI semiconductor ecosystem. The community is actively debating the stock's parabolic move, with many bulls focusing on a short squeeze as the primary driver while cautioning that significant execution risks remain.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos is experiencing increased social chatter as community members discuss a significant redesign of its tokenomics to transition from inflationary rewards to a revenue-based model. While some traders are expressing frustration over the recent price performance compared to broader crypto markets, others remain focused on the potential for long-term sustainability through increased utility and inter-chain connectivity.

"KISHU INU was created in April 2021 with the goal of being a decentralized meme project with true purpose.  KISHU’s mission is to bring popular cryptocurrency concepts to the mainstream. Unlike older, comparable projects, KISHU introduces holders to next-gen concepts such as participation rewards, NFTs, decentralized exchanges, and more.  Within the first month of its launch, KISHU made history by surpassing a $2 billion market cap and over 100,000 holders. This was an unprecedented milestone for a project of its kind, and proved the world’s belief in the project."

KISHU INU

Kishu Inu is capturing community attention as a perceived "sleeping giant," with holders actively discussing its potential to replicate the parabolic growth of other major meme coins while betting on a long-term comeback. The discussion is heavily centered on building conviction during periods of low activity, with many retail investors citing the coin's massive holder base and hopes for future exchange listings as catalysts for a potential rally.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is drawing significant community attention as investors position themselves ahead of the upcoming XRP Las Vegas conference, with many participants actively discussing potential institutional partnerships and long-term utility. While some users express skepticism and label the asset a pump-and-dump scheme, supporters are aggressively accumulating, viewing the current price levels as a strategic entry point for multi-year growth.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) is currently at the center of a heated debate as traders weigh its historic multi-week winning streak against warnings from researchers that the sector has become dangerously overextended. Community sentiment is deeply divided between those betting on an inevitable, sharp mean reversion and investors who view the rally as a sign of continued dominance in AI-driven infrastructure.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as the stock surges toward new all-time highs, reclaiming a massive market capitalization and leading a broad rally across the semiconductor sector following upbeat earnings sentiment from peers like Intel. The community is actively debating the sustainability of this AI-driven momentum, with intense discussions centered on whether this breakout signals the next leg of a generational bull market or an overextended bubble ready for a correction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zurcher Kantonalbank Zurich Cantonalbank Acquires 219,479 Shares of Royalty Pharma PLC $RPRX

Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 222.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 318,293 shares of the biopharmaceutical comp...

Royalty Pharma PLC $RPRX Shares Purchased by Torray Investment Partners LLC

Torray Investment Partners LLC increased its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 5.9% in the fourth quarter, according to the company in its most recent filing...

Royalty Pharma PLC (NASDAQ:RPRX) Receives Consensus Recommendation of "Buy" from Analysts

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) has been assigned a consensus rating of "Buy" from the six brokerages that are presently covering the company, Marketbeat.com reports. Six research...

Moran Wealth Management LLC Grows Position in Royalty Pharma PLC $RPRX

Moran Wealth Management LLC boosted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 20.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange...

KBC Group NV Trims Holdings in Royalty Pharma PLC $RPRX

KBC Group NV trimmed its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 13.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 163,561 shares of the biopharmaceutical...

Royalty Pharma PLC (NASDAQ:RPRX) Declares $0.24 Quarterly Dividend

Royalty Pharma PLC (NASDAQ:RPRX) declared a quarterly dividend on Friday, April 17th. Shareholders of record on Friday, May 15th will be given a dividend of 0.235 per share by the biopharmaceutical...

Royalty Pharma (NASDAQ:RPRX) Hits New 1-Year High  - Should You Buy?

Royalty Pharma (NASDAQ:RPRX) Reaches New 52-Week High - Time to Buy...

Sumitomo Mitsui Trust Group Inc. Acquires 166,403 Shares of Royalty Pharma PLC $RPRX

Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 15.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,268,044 shares of the biopharmaceutical company's stock aft...

Foster Victor Wealth Advisors LLC Takes Position in Royalty Pharma PLC $RPRX

Foster Victor Wealth Advisors LLC acquired a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund...

Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive?

Royalty Pharma (RPRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

RPRX
Royalty Pharma plc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RPRX News

RPRXRoyalty Pharma plc - Ordinary Shares - Class A